Comparison of Fluid Rapid Influenza and BinaxNOW Influenza A & B
Phase 3
Suspended
- Conditions
- Influenza
- First Posted Date
- 2009-01-23
- Last Posted Date
- 2009-03-06
- Lead Sponsor
- Nanogen, Inc.
- Target Recruit Count
- 650
- Registration Number
- NCT00828100
- Locations
- 🇺🇸
Louisiana State University Health Sciences Center, Shreveport, Louisiana, United States
🇺🇸Medical College of Wisconsin, Milwaukee, Wisconsin, United States
Prospective Evaluation of the Fluid Rapid Influenza Test
Phase 3
Suspended
- Conditions
- Influenza
- Interventions
- Device: fluID Rapid Influenza Test
- First Posted Date
- 2009-01-22
- Last Posted Date
- 2009-04-15
- Lead Sponsor
- Nanogen, Inc.
- Target Recruit Count
- 1300
- Registration Number
- NCT00826709
- Locations
- 🇺🇸
Hennepin County Medical Center, Minneapolis, Minnesota, United States
🇺🇸University Clinical Research - DeLand, LLC, DeLand, Florida, United States
🇺🇸The Family Doctor Research, Shreveport, Louisiana, United States
Prospective Evaluation of the StatusFirstâ„¢ CHF NT-proBNP Device in Human Whole Blood and Plasma Samples
Completed
- Conditions
- Congestive Heart Failure (CHF)
- First Posted Date
- 2008-08-13
- Last Posted Date
- 2008-12-10
- Lead Sponsor
- Nanogen, Inc.
- Target Recruit Count
- 450
- Registration Number
- NCT00734045
- Locations
- 🇺🇸
US Department of Veteran's Affairs, San Diego, California, United States
🇺🇸San Francisco General Hospital, San Francisco, California, United States
© Copyright 2025. All Rights Reserved by MedPath